2025 Publications

  1. Halloran PF, Madill-Thomsen KS, Bohmig G, Bromberg J, Budde K, Barner M, et al. Subthreshold rejection activity in many kidney transplants currently classified as having no rejection. Am J Transplant. 2025;25(1):72-87.
  2. Halloran PF, Madill-Thomsen KS. Donor-derived Cell-free DNA: A Step Forward in the Quest for Transplant Truth. Transplantation 2025;109(6):910-914.
  3. Halloran PF, Chang J, Mackova M, Madill-Thomsen KS, et al. A cross-sectional study of the role of epithelial cell injury in kidney transplant outcomes. JCI Insight 2025;10(10):e188658.
  4. Madill-Thomsen KS, Venner JM, et al. Relating the molecular phenotype of ulcerative colitis to the clinical course. Nature Scientific Reports 2025;15(1):8342.
  5. Madill-Thomsen KS, Hidalgo LG, Demko Z, Gauthier PM, et al. Defining relationships among tests for kidney transplant antibody-mediated rejection. KI Reports 2025; 10(9):3225-38. 
  6. Hinze C, Pfefferkorn AM, Jahn L, Gauthier PT, Leiz J, Safraz S, et al. Thick ascending limb injury critically impacts kidney allograft survival after T-cell-mediated rejection. Nature Communications. 2025;https://doi.org/10.21203/rs.3.rs-5683198/v1.
  7.  Hidalgo LG, Madill-Thomsen KS, Reeve J, Investigators T-K, Halloran PF. Improving the histologic detection of DSA-negative antibody-mediated rejection in kidney transplants. Am J Transplant. 2025;In press.(https://doi.org/10.1016/j.ajt.2025.08.029).
  8. Diebold M, Gauthier PT, Mayer KA, Mackova M, Hinze C, Chang J, et al. Effect of felzartamab on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies. Nat Med. 2025;31(5):1668-76.
  9. Zhang R, Lee CYC, Schatzl M, Budde K, Halleck F, Jilma B, et al. The Effects of Clazakizumab on Peripheral Blood and Kidney Transcriptomes in Patients With Late Antibody-Mediated Rejection. Kidney International Reports. In press.
  10. Hidalgo LG, Madill-Thomsen KS, Reeve J, Investigators T-K, Halloran PF. Improving the histologic detection of DSA-negative antibody-mediated rejection in kidney transplants. Am J Transplant. 2025;In press.(https://doi.org/10.1016/j.ajt.2025.08.029).
  11. Mackova M, Gauthier P, Chang J, Hirji A, Weinkauf J, Juvet S, et al. Molecular biopsy features associated with baseline lung allograft dysfunction in a multicenter international cohort. J Heart Lung Transplant. 2025.

  12. Madill-Thomsen KS, Hidalgo LG, Mackova M, Campbell P, Demko Z, Felius J, et al. Defining the relationships among four tests for assessing antibody-mediated rejection in heart transplants in a prospective, observational study. Journal of Heart and Lung Transplantation. 2025;In press.